Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat obesity and associated diseases (2008)

  • Authors:
  • USP affiliated authors: CAMPOS, FABIO GUILHERME CASERTA MARYSSAEL DE - FM
  • USP Schools: FM
  • DOI: 10.1007/s11695-007-9371-0
  • Subjects: OBESIDADE MÓRBIDA (CIRURGIA); PEPTÍDEOS; OMENTO (CIRURGIA)
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s11695-007-9371-0 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Obesity Surgery

    ISSN: 0960-8923

    Citescore - 2017: 2.92

    SJR - 2017: 1.396

    SNIP - 2017: 1.219


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM10700091688-SFM BCSEP 018 2008
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SANTORO, Sergio; MILLEO, Fábio Quirilo; MALZONI, Carlos Eduardo; et al. Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat obesity and associated diseases. Obesity Surgery, Oxford, v. 18, n. 1, p. 17-26, 2008. DOI: 10.1007/s11695-007-9371-0.
    • APA

      Santoro, S., Milleo, F. Q., Malzoni, C. E., Santo, M. A., Campos, F. G., & Artoni, R. F. (2008). Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat obesity and associated diseases. Obesity Surgery, 18( 1), 17-26. doi:10.1007/s11695-007-9371-0
    • NLM

      Santoro S, Milleo FQ, Malzoni CE, Santo MA, Campos FG, Artoni RF. Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat obesity and associated diseases. Obesity Surgery. 2008 ; 18( 1): 17-26.
    • Vancouver

      Santoro S, Milleo FQ, Malzoni CE, Santo MA, Campos FG, Artoni RF. Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat obesity and associated diseases. Obesity Surgery. 2008 ; 18( 1): 17-26.

    Referências citadas na obra
    Drazen DL, Woods SC. Peripheral signals in the control of satiety and hunger. Curr Opin Clin Nutr Metabol Care 2003;6:621–9.
    Ranganath LR, Beety JM, Morgan LM, et al. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996;38(6):916–9.
    Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 2003;994:162–8.
    Santoro S, Velhote MCP, Malzoni CE, et al. Digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Einstein 2003;1(2):99–104.
    Santoro S, Velhote MCP, Malzoni CE, et al. Preliminary results of digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Sao Paulo Med J 2006;124(4):192–7.
    Santoro S, Malzoni CE, Velhote MCP, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based procedure for morbid obesity. Obes Surg 2006;16(10):1371–79.
    Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg 2007;17:565–8.
    Kenler HA, Brolin RE, Cody RP. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr 1990;52:87–92.
    Le Roux CW, Aylwin SJB, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anoretic state, facilitate weight loss and improve metabolic parameters. Ann Surg 2006;243:108–14.
    Stevens CE, Hume ID. Comparative physiology of the vertebrate digestive system. The mammalian gastrointestinal tract. Cambridge, United Kingdom: Cambridge University Press; 1995, p. 46–96.
    Milton K. Primate diets and gut morphology: implications for human evolution. In: Harris M, Ross EB, editors. Food and Evolution. Toward a theory of human food habits. Philadelphia: Temple University Press; 1987.
    Milton K. A hypothesis to explain the role of meat-eating in human evolution. Evol Anthropol 1999;8:11–21.
    Aiello LC, Wheeler P. The expensive tissue hypothesis: the brain and the digestive system in human and primate evolution. Curr Anthropol 1995;36:199–221.
    Leonard WR, Robertson ML. Evolutionary perspectives on human nutrition: the influence of brain and body size on diet and metabolism. Am J Hum Biol 1994;6:77–88.
    Lugari R, Dei Cas A, Ugolotti D, et al. Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes. Horm Metab Res 2002;34(3):150–4.
    Hounnou G, Destrieux C, Desme J, et al. Anatomical study of the length of the human intestine. Surg Radiol Anat 2002;24(5):290–4.
    Muccioli G, Tschop M, Papotti M, et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002;440(2–3):235–54.
    Adkins RB Jr, Davies J. Gross and microscopic anatomy of the stomach and small intestine. In: Scott HW Jr, Sawyers JL, editors. Surgery of the stomach, duodenum and small bowel. Boston: Blackwell Scientific Publications; 1987. p. 45–60.
    Tolessa T, Gutniak M, Holst JJ, et al. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 1998;102:764–74.
    Lin HC, Neevel C, Chen JH. Slowing intestinal transit by PYY depends on serotonergic and opioid pathways. Am J Physiol Gastrointest Liver Physiol 2004;286:G558–63.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292(14):1724–37.
    Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide-1: a physiological incretin man. Lancet 1987;2(8571):1300–4.
    Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood–brain barrier. J Mol Neurosci 2002;18:7–14.
    Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 2003;994:162–8.
    van den Hoek AM, Heijboer AC, Corssmit EP, et al. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 2004;53(8):1949–52.
    Byrne TK. Complications of surgery for obesity. Surg Clin North Am 2001;81(5):1181–93.
    Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999;9(3):223–8.
    de Paula AL, Macedo AL, Prudente AS, et al. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)—pilot study of a new operation. Surg Obes Relat Dis 2006;2(4):464–7.
    Thulesen J. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator. Current Protein and Peptide Science 2004;5(1):51–65.
    Thulesen J, Hartmann B, Kissow H, et al. Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection. Dig Dis Sci 2001;46(2):379–88.
    Santoro S. Hipertrofia intestinal induzida por alimento e obesidade. Einstein 2005;3(4):310–2.
    Santoro S, Velhote MCP, Malzoni CE, et al. Preliminary report: adaptive entero-omentectomy: physiological and evolutionary bases of an auxiliary treatment to type 2 diabetes. A report on the first two cases. Einstein 2004;2(3):193–98.
    Milleo FQ, Malafaia O, Nassif PAN, et al. Comparative study of the effect of the Capella and Santoro Type II surgical techniques for treatment of obesity regarding BMI and peripheral triglyceridemia. Rev Bras Videocir 2006;4(4):151–61.
    Meier JJ, Gethmann A, Götze O, et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 2006;49:452–8.
    Felber JP. Significance of the Randle-Mechanism in the etiology of diabetes type II. Horm Metab Res Suppl 1990;22:11–7.
    Rahmouni K, Correia ML, Haynes WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45(1):9–14.
    Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143–421.
    Bergman RN, Van Citters GW, Mittelman SD, et al. Central role of the adipocyte in the metabolic syndrome. J Investig Med 2001;49(1):119–26.
    McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002;359(9300):46–7.
    McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002;87(5):2407.
    Hansen E, Hajri T, Abunmrad NN. Is all fat the same? The role of fat in the pathogenesis of metabolic syndrome and type 2 diabetes mellitus. Surgery 2006;139(6):711–6.